FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
IMMULISA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY (ASCA) (IGA)
K Number: K032860
·
Decision Mar 18, 2004
Classifications
1
FEI Numbers
5
Registration Numbers
5
Same Product Code
7
Applicant Total
55
Review Days
188
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- IMMULISA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY (ASCA) (IGA)
- K Number
- K032860
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.5785
- Medical Specialty
- Immunology
- Decision
- Substantially Equivalent
- Statement or Summary
- Statement
- Applicant
- Immco Diagnostics, Inc.
- Date Received
- September 12, 2003
- Decision Date
- March 18, 2004
- Product Code
- NBT
- Advisory Committee
- Immunology
- Review Advisory Committee
- IM
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NBT | Antibodies, Saccharomyces Cerevisiae (S.Cerevisiae) | FDA class 2 | Immunology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (NBT), ordered by most recent decision date.
ASCA-CHEK
FDA 510(k)
FDA Class 2
·Immunology
TECHLAB ASCA-CHEK
FDA 510(k)
FDA Class 2
·Immunology
AESKULISA ASCA A
FDA 510(k)
FDA Class 2
·Immunology
BINDAZYME HUMAN ASCA IGG AND IGA EIA DIAGNOSTIC TEST KIT
FDA 510(k)
FDA Class 2
·Immunology
IMMULISA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY (ASCA) (IGG)
FDA 510(k)
FDA Class 2
·Immunology
QUANTA LITE ASCA (S. CEREVISIAE) IGA ELISA
FDA 510(k)
FDA Class 2
·Immunology
Other Clearances by Immco Diagnostics, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K172745 | ImmuGlo HEp-2 Elite IFA | Jun 5, 2018 | Substantially Equivalent |
| K172078 | ImmuLisa Enhanced RNA POL III Antibody ELISA | Mar 30, 2018 | Substantially Equivalent |
| K163133 | ImmuLisa Enhanced AMA IgG Antibody ELISA; ImmuLisa Enhanced AMA IgA/IgG/IgM Antibody ELISA | Aug 8, 2017 | Substantially Equivalent |
| K163177 | ImmuLisa Enhanced Gliadin IgA Antibody ELISA, ImmuLisa Enhanced Gliadin IgG Antibody ELISA | Jul 28, 2017 | Substantially Equivalent |
| K162788 | ImmuLisa Enhanced B2GP1 IgA Antibody ELISA, ImmuLisa Enhanced B2GP1 IgG Antibody ELISA, ImmuLisa Enhanced B2GP1 IgM Antibody ELISA, ImmuLisa Enhanced B2GP1 IgA/IgG/IgM Antibody ELISA | Jun 19, 2017 | Substantially Equivalent |
| K151559 | ImmuLisa Enhanced Centromere Antibody ELISA | Mar 11, 2016 | Substantially Equivalent |
| K143736 | ImmuLisa Enhanced RF IgA Antibody ELISA, ImmuLisa Enhanced RF IgG Antibody ELISA, ImmuLisa Enhanced RF IgM Antibody ELISA, ImmuLisa Enhanced RF Antibody Screen ELISA | Sep 23, 2015 | Substantially Equivalent |
| K142781 | ImmuLisa Enhanced SS-A (Ro) Antibody ELISA, ImmuLisa Enhanced SS-B (La) Antibody ELISA, ImmuLisa Enhanced Sm Antibody ELISA, ImmuLisa Enhanced RNP Antibody ELISA | Mar 31, 2015 | Substantially Equivalent |
| K123713 | IMMULISA ENHANCED CELIAC FUSION (TTG/DGP) IGA/IGG ANTIBODY ELISA | Oct 25, 2013 | Substantially Equivalent |
| K113020 | IMMULISA ENHANCED (TM) CARDIOLIPIN IGA, IGG, IGM AND IGA/IGG/IGM ANTIBODY (ACA) ELISAS | Oct 25, 2012 | Substantially Equivalent |